Number of (in total about 120 individuals, at least individuals trained; 30% women); Train the trainer's approach; COMPONENT 2: ENHANCING SYSTEM FOR RISK ASSESSMENT (RA), RISK MANAGEMENT (RM), AND RISK COMMUNICATION (RC) Outcome 2.1: National institutions strengthened for RA, RM and RC including monitoring and enforcement Outcome 2.1: Number of agencies The capacity of All members, bodies and relevant Training outcome Risks National that have national institutions agencies received institutionalized report; Lack of consensus for institutions institutionalised is limited to enable training and they are capable to work procedures/guidelines for RA, RM strengthened for training on RA, RM formulation and with the RA, RM and RC framework; and RC among institutions; RA, RM and RC and RC; implementation of Capacity including integrated and Lack of trained personals in each development survey monitoring and Number of focal coherent biosafety institution involved on how to At least 3 focal points identified for of focal points (e.g. enforcement points for RA, RM regulatory perform RA and how to go about institutional RA, RM and RC; before/ after training and RC in each mechanisms; RM; survey with annual institution identified; review, Assumptions ToR of each institution available; 1 institutional mechanism in place to (KAP) survey); deal with biosafety issues in the Institutionalized training approach country; provided; Training program and guidelines developed based on both national and international experience; Output 2.1.1: Number of guidelines Guidelines for the At least 1 comprehensive guideline Updated guidelines Risks Methodologies for contained use and safe use of available for GMOs/LMOs in for the use of National experience in various for RA, RM and Risk Analysis Recombinant DNA contained conditions including green GMOs/LMOs under cases of RA, RM and RC not RC reviewed, Framework technology in house, net house etc.; contained conditions available; refined and developed; contained conditions in place and notified; updated available but not At least 1 Risk Analysis Framework Assumptions mandated; Risk Analysis Framework in place
Number of individuals trained; (in total about 120 individuals, at least 30% women); Train the trainer's approach; COMPONENT 2: ENHANCING SYSTEM FOR RISK ASSESSMENT (RA), RISK MANAGEMENT (RM), AND RISK COMMUNICATION (RC) Outcome 2.1: National institutions strengthened for RA, RM and RC including monitoring and enforcement Outcome 2.1: National institutions strengthened for RA, RM and RC including monitoring and enforcement Number of agencies that have institutionalised training on RA, RM and RC; Number of focal points for RA, RM and RC in each institution identified; The capacity of national institutions is limited to enable formulation and implementation of integrated and coherent biosafety regulatory mechanisms; All members, bodies and relevant agencies received institutionalized training and they are capable to work with the RA, RM and RC framework; At least 3 focal points identified for institutional RA, RM and RC; 1 institutional mechanism in place to deal with biosafety issues in the country; Training outcome report; Capacity development survey of focal points (e.g. before/ after training survey with annual review, (KAP) survey); Risks Lack of consensus for procedures/guidelines for RA, RM and RC among institutions; Lack of trained personals in each institution involved on how to perform RA and how to go about RM; Assumptions ToR of each institution available; Institutionalized training approach provided; Training program and guidelines developed based on both national and international experience; Output 2.1.1: Methodologies for RA, RM and RC reviewed, refined and updated Number of guidelines for contained use and Risk Analysis Framework developed; Guidelines for the safe use of Recombinant DNA technology in contained conditions available but not mandated; At least 1 comprehensive guideline available for GMOs/LMOs in contained conditions including green house, net house etc.; At least 1 Risk Analysis Framework Updated guidelines for the use of GMOs/LMOs under contained conditions in place and notified; Risk Analysis Framework in place Risks National experience in various cases of RA, RM and RC not available; Assumptions
03-30-16_CEO_Endorsement_GEF5_FAO_SRL_Biosafety_230320161_0.docx